(NASDAQ: ASPI) Asp Isotopes's forecast annual revenue growth rate of 97.46% is forecast to beat the US Chemicals industry's average forecast revenue growth rate of 3.01%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.42%.
Asp Isotopes's revenue in 2026 is $30,852,050.On average, 5 Wall Street analysts forecast ASPI's revenue for 2026 to be $4,696,326,238, with the lowest ASPI revenue forecast at $3,305,350,233, and the highest ASPI revenue forecast at $5,795,094,564. On average, 5 Wall Street analysts forecast ASPI's revenue for 2027 to be $12,898,531,377, with the lowest ASPI revenue forecast at $10,471,950,510, and the highest ASPI revenue forecast at $14,453,395,109.
In 2028, ASPI is forecast to generate $40,246,778,438 in revenue, with the lowest revenue forecast at $33,127,090,830 and the highest revenue forecast at $47,367,999,139.